Endo Net Income 2006-2019 | ENDP

Endo net income from 2006 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Endo Annual Net Income
(Millions of US $)
2019 $-423
2018 $-1,031
2017 $-2,035
2016 $-3,347
2015 $-1,495
2014 $-721
2013 $-685
2012 $-740
2011 $188
2010 $259
2009 $266
2008 $255
2007 $227
2006 $138
2005 $202
Endo Quarterly Net Income
(Millions of US $)
2019-12-31 $-219
2019-09-30 $-79
2019-06-30 $-106
2019-03-31 $-19
2018-12-31 $-292
2018-09-30 $-173
2018-06-30 $-61
2018-03-31 $-505
2017-12-31 $-368
2017-09-30 $-97
2017-06-30 $-1,397
2017-03-31 $-174
2016-12-31 $-3,338
2016-09-30 $-219
2016-06-30 $344
2016-03-31 $-134
2015-12-31 $-118
2015-09-30 $-1,050
2015-06-30 $-250
2015-03-31 $-76
2014-12-31 $-53
2014-09-30 $-252
2014-06-30 $21
2014-03-31 $-437
2013-12-31 $-776
2013-09-30 $40
2013-06-30 $35
2013-03-31 $15
2012-12-31 $-716
2012-09-30 $54
2012-06-30 $9
2012-03-31 $-87
2011-12-31 $37
2011-09-30 $41
2011-06-30 $55
2011-03-31 $56
2010-12-31 $93
2010-09-30 $54
2010-06-30 $51
2010-03-31 $60
2009-12-31 $148
2009-09-30 $49
2009-06-30 $30
2009-03-31 $39
2008-12-31 $73
2008-09-30 $66
2008-06-30 $57
2008-03-31 $60
2007-12-31 $51
2007-09-30 $59
2007-06-30 $61
2007-03-31 $57
2006-12-31 $15
2006-09-30 $45
2006-06-30 $58
2006-03-31 $21
2005-12-31 $73
2005-09-30 $67
2005-06-30 $49
2005-03-31 $14
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.728B $2.914B
Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel for pain, urology, endocrinology, and oncology. The company also provides non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets. Endo International plc, formerly known as Endo Pharmaceuticals Holdings Inc., is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $60.217B 34.83
Takeda Pharmaceutical (TAK) Japan $48.868B 8.56
Astellas Pharma (ALPMY) Japan $29.371B 14.67
Eisai (ESALY) Japan $20.251B 37.73
UCB SA (UCBJF) Belgium $15.687B 0.00
Grifols, S.A (GRFS) Spain $13.311B 16.55
Merck (MKGAF) Germany $12.924B 16.95
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $8.419B 233.90
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.874B 0.00
Catalent (CTLT) United States $7.671B 31.56
Ionis Pharmaceuticals (IONS) United States $7.164B 21.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.906B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.937B 7.24
Orion OYJ (ORINY) Finland $5.269B 23.61
STADA ARZNEIMI (STDAF) Germany $4.685B 0.00
IPSEN SA ADR (IPSEY) France $4.656B 0.00
Forty Seven (FTSV) United States $4.599B 0.00
United Therapeutics (UTHR) United States $4.202B 0.00
Evotec AG (EVTCY) Germany $3.580B 57.74
Hypermarcas (HYPMY) Brazil $3.462B 10.53
Nektar Therapeutics (NKTR) United States $3.207B 0.00
FibroGen (FGEN) United States $3.159B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.942B 54.60
PTC Therapeutics (PTCT) United States $2.816B 0.00
ChemoCentryx (CCXI) United States $2.682B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.440B 9.87
Xencor (XNCR) United States $1.805B 73.70
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.684B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.593B 19.36
USANA Health Sciences (USNA) United States $1.511B 15.86
Sage Therapeutics (SAGE) United States $1.473B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.467B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.345B 36.78
Corcept Therapeutics (CORT) United States $1.322B 14.80
Karyopharm Therapeutics (KPTI) United States $1.255B 0.00
Heron Therapeutics (HRTX) United States $1.155B 0.00
Zogenix (ZGNX) United States $1.047B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.012B 31.34
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.940B 13.08
Akebia Therapeutics (AKBA) United States $0.921B 0.00
Esperion Therapeutics (ESPR) United States $0.879B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.759B 0.00
Molecular Templates (MTEM) United States $0.632B 0.00
Tilray (TLRY) Canada $0.620B 0.00
Translate Bio (TBIO) United States $0.620B 0.00
ImmunoGen (IMGN) United States $0.607B 0.00
Radius Health (RDUS) United States $0.603B 0.00
Collegium Pharmaceutical (COLL) United States $0.602B 0.00
Aerie Pharmaceuticals (AERI) United States $0.557B 0.00
Portola Pharmaceuticals (PTLA) United States $0.552B 0.00
Siga Technologies (SIGA) United States $0.432B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.411B 16.86
Indivior (INVVY) United States $0.408B 2.43
Catalyst Pharmaceuticals (CPRX) United States $0.405B 13.52
Innate Pharma SA (IPHYF) France $0.385B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.376B 0.00
Ardelyx (ARDX) United States $0.376B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.360B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.329B 0.00
Trillium Therapeutics (TRIL) Canada $0.329B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.316B 0.00
Organogenesis Holdings (ORGO) United States $0.315B 0.00
Calithera Biosciences (CALA) United States $0.307B 0.00
Flexion Therapeutics (FLXN) United States $0.299B 0.00
Harpoon Therapeutics (HARP) United States $0.296B 0.00
Lannett Co Inc (LCI) United States $0.294B 4.73
DURECT (DRRX) United States $0.284B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.271B 0.00
Ocular Therapeutix (OCUL) United States $0.271B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.268B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.262B 0.00
TherapeuticsMD (TXMD) United States $0.251B 0.00
Concert Pharmaceuticals (CNCE) United States $0.249B 0.00
Rafael Holdings (RFL) United States $0.207B 0.00
CASI Pharmaceuticals (CASI) United States $0.192B 0.00
Recro Pharma (REPH) United States $0.187B 0.00
OptiNose (OPTN) United States $0.179B 0.00
Jounce Therapeutics (JNCE) United States $0.169B 3.04
PROFOUND MEDICL (PROF) Canada $0.166B 0.00
MEI Pharma (MEIP) United States $0.165B 0.00
Nature's Sunshine Products (NATR) United States $0.157B 19.61
La Jolla Pharmaceutical (LJPC) United States $0.156B 0.00
Taiwan Liposome (TLC) Taiwan $0.136B 0.00
KalVista Pharmaceuticals (KALV) United States $0.135B 0.00
Redhill Biopharma (RDHL) Israel $0.123B 0.00
VAXART, INC (VXRT) United States $0.122B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.104B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.102B 0.00
CannTrust Holdings (CTST) Canada $0.090B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.087B 0.00
IMV INC (IMV) Canada $0.087B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.085B 0.00
SCYNEXIS (SCYX) United States $0.082B 0.00
Champions Oncology (CSBR) United States $0.079B 0.00
Hemispherx BioPharma (AIM) United States $0.079B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.076B 0.00
Xeris Pharmaceuticals (XERS) United States $0.075B 0.00
Aquestive Therapeutics (AQST) United States $0.071B 0.00
CTI BioPharma (CTIC) United States $0.071B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.069B 0.00
Biomerica (BMRA) United States $0.069B 0.00
CV Sciences (CVSI) United States $0.067B 0.00
Otonomy (OTIC) United States $0.061B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.055B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.054B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.054B 16.86
Nivalis Therapeutics (ALPN) United States $0.051B 0.00
Infinity Pharmaceuticals (INFI) United States $0.050B 0.00
Onconova Therapeutics (ONTX) United States $0.048B 0.00
Aclaris Therapeutics (ACRS) United States $0.048B 0.00
PharmAthene (ALT) United States $0.046B 0.00
Natural Alternatives (NAII) United States $0.045B 20.31
Sundial Growers (SNDL) Canada $0.044B 0.00
GTx (ONCT) United States $0.044B 0.00
MediWound (MDWD) Israel $0.041B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 135.43
Neos Therapeutics (NEOS) United States $0.039B 0.00
Forward Pharma (FWP) Denmark $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
PolarityTE (PTE) United States $0.036B 0.00
AgeX Therapeutics (AGE) United States $0.035B 0.00
IsoRay (ISR) United States $0.034B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.031B 0.00
Heat Biologics (HTBX) United States $0.030B 0.00
ElectroCore (ECOR) United States $0.028B 0.00
Cardiome Pharma (CORV) Canada $0.025B 0.00
Jaguar Animal Health (JAGX) United States $0.025B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.024B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.024B 0.00
Mannatechorporated (MTEX) United States $0.023B 7.32
Adamis Pharmaceuticals (ADMP) United States $0.023B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Lipocine (LPCN) United States $0.021B 0.00
India Globalization Capital (IGC) United States $0.018B 0.00
Bio-Path Holdings (BPTH) United States $0.017B 0.00
Novan (NOVN) United States $0.017B 0.00
Can-Fite Biopharma (CANF) Israel $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Shineco (TYHT) China $0.011B 0.00
KemPharm (KMPH) United States $0.011B 0.00
Vical (BBI) United States $0.011B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
HANCOCK JAFFE (HJLI) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.003B 0.00